The increase of pseudomonas aeroginosa positivity in samples from patients carrying the novo coronavirus
DOI:
https://doi.org/10.33448/rsd-v11i10.19040Keywords:
Pseudomonas aeruginosa; Disinfection; COVID-19; Health.Abstract
In 2019, the first cases of the new virus in the world began, in the city of Wuhan, China. As it is easy to spread, it quickly arrived in Brazil in February 2020, being declared a pandemic. The virus is transmitted through the airways, so new methods were used for possible control of the disease. This work intends to evaluate articles that talk about the prevalence of Pseudomonas aeruginosa in samples of patients with the new coronavirus, in order to present this prevalence so that they can be analyzed and used for future publications. All publications that had data on the prevalence of Pseudomonas aeroginosa in samples of patients with the new coronavirus, scientific publications, official publications of the World Health Organization (WHO) and government, within a given date (2019-2021) were used. Data were collected using the following scientific databases: Latin American and Caribbean Literature on Health Sciences (LILACS), National Library of Medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library – (BVS), Scientific Electronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. A total of 3,011 articles were found (Table 1) in the scientific databases: Latin American and Caribbean Literature on Health Sciences (LILACS), National Library of Medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library – (BVS), Scientific Electronic Library Online (SCIELO), Cochrane Library, HighWire Press, Scopus and Elsevier. The following descriptors were used: Pseudomonas aeruginosa, HOSPITAL INFECTION, SARS-COV-2, COVID 19 in English, Portuguese and Spanish. Based on the results of this research, we saw that there is a greater need for the creation of standardization of protocols, for the reduction of cases and also for cleaning. We need more work and research for data renewal and a greater update for the population.
References
Chughtai, A. A., Seale, H., Islam, M. S., Owais, M., Macintyre, C. R. (2020). Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19). Int J Nurs Stud; 105:103567.
Clinical and Laboratory Standards Institute. (2021). Performance Standards for Antimicrobial Susceptibility Testing, 31st edition. Supplement M100. Pittsburgh, PA: CLSI.
Costa, D. B., Ramos, D., Gabriel, C. S., Bernardes, A. (2018). Patient safety culture: evaluation by nursing professionals. Texto Contexto Enfermagem [Internet].
Da Cunha, R. S. R., Carniel, E., Narvaez, G. A., Dias, C. G., Perez, L. R. R. (2021). Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa. Am J Infect Control; 49:352–354.
Ferioli, M., Cisternino, C., Leo, V., Pisani, L., Palange, P., Nava, S. (2020). Protegendo os profissionais de saúde da infecção por SARS-CoV-2: indicações práticas. Eur Respir R. 29(155): 200068.
Galetti, R., Andrade, L. N., Varani, A. M., Darini, A. L. C. S. P. M. (2019).1–producing Pseudomonas aeruginosa ST277 carries a chromosomal pack of acquired resistance genes: an example of high-risk clone associated with 'intrinsic resistome'. J Glob Antimicrob Resist 2019; 16:183–186.
Gallasch, C. H., Cunha, M. L., Pereira, L. A. S., Silva-Junior, J. S. (2020). Prevenção relacionada à exposição ocupacional do profissional de saúde no cenário de COVID-19. Rev enferm UERJ. 28:e49596.
Gaudereto, J. J., Perdigão, Neto, L. V., Leite, G. C., et al. (2019). Synergistic effect of ceftazidime-avibactam with meropenem against panresistant, carbapenemase-harboring Acinetobacter baumannii and Serratia marcescens investigated using time-kill and disk approximation assays. Antimicrob Agents Chemother. 63:e02367–18.
Hopkins, J. (2020). New Cases of COVID-19 In World Countries. University and medicine. [Internet].
Khan, A., Shropshire, W. C., Hanson, B., et al. (2020). Simultaneous infection with Enterobacteriaceae and Pseudomonas aeruginosa harboring multiple carbapenemases in a returning traveler colonized with Candida auris. Antimicrob Agents Chemother. 64:e01466–19.
Linciano, P., Cendron, L., Gianquinto, E., Spyrakis, F., Tondi, D. (2019). Ten Years with New Delhi metallo-beta-lactamase-1 (NDM-1): from structural insights to inhibitor design. ACS Infect Dis. 5:9–34.
Livermore, D. (1992). Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 36:2046–2048.
Marshall, S., Hujer, A. M., Rojas, L. J., et al. (2017). Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? Antimicrob Agents Chemother. 61:e02243–16.
Miranda, V. S. G., Rech, R. S., Maahs, M. A. P. (2020). Relatos. Revista Enfermagem ATUAL IN Derme | Edição Especial Covid19. e-020013.
NOTA TÉCNICA GVIMS/GGTES/ANVISA Nº 07/2020 Orientações para prevenção e vigilância epidemiológica das infecções por SARS-COV-2 (Covid- 19) dentro dos serviços de saúde.
Organização Pan-americana da Saúde (OPAS). (2020). Folha informativa – COVID-19 (doença causada pelo novo coronavírus) [Internet]. Brasília.
Perez, F, El Chakhtoura, N. G., Pappwallace, K. M., Wilson, B. M., Bonomo, R. A. (2016). Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? Expert Opin Pharmacother. 17:761–781.
Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2:65.
World Health Organization. (2019b). Report of the WHO-China Joint Mission on Coronavirus Disease. (COVID-19).
World Health Organization. (2019a). Rolling updates on coronavirus disease (COVID-19).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Kelly Maria Rêgo da Silva; Luiz Fernando Pereira de Sá; João Paulo de Oliveira Mata; Atílio da Silva Teixeira; Antonio Vinícius Sales de Moraes Souza Crisanto; Gabriela Rodrigues Amorim; Flávia Piauilino Pinheiro; Luana Araújo Martins ; Ícaro Avelino Silva; Ana Patricia de Oliveira; Maria Pereira de Queiroga Aguiar; Ulisses Nogueira de Aguiar; Walquer Vinicius Esteves Gonçalves; Amanda Miranda da Silva; Kivia Ludmilla Carvalho Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
